University of Miami Cancer Center — Miami, Florida

University of Miami Cancer Center is a clinical research site located in Miami, Florida, United States 33136.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Miami Cancer Center has participated in 7 clinical trials.

Therapeutic areas: Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma, Relapsed Acute Myelogenous Leukemia.

Sponsors: Therapeutic Advances in Childhood Leukemia Consortium, Dendreon.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Miami Cancer Center?

University of Miami Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Miami Cancer Center conducted?

University of Miami Cancer Center has 7 clinical trials on record. Their work covers Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma, Relapsed Acute Myelogenous Leukemia.

Is University of Miami Cancer Center accredited by Crixeo Health?

Yes — University of Miami Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Miami Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.